Edwards Lifesciences’ artificial aortic valve technology opens the way for innovative heart surgery, which promises to reduce costs, as well as patient recovery time.
Portfolio Risk Analyst
Sands Capital (2017 - 2020)
Arlington, VA | Portfolio Analyst
Sands Capital (2016 - 2017)
Arlington, VA | Associate Portfolio Data Analyst
T. Rowe Price (2013 - 2015)
Baltimore, MD | Business Analyst
Ashmore Equity Investment Management (2012 - 2013)
Arlington, VA | Research Associate
University of Maryland - BA, Economics (2011)
Duke University - MBA, Fuqua School of Business (2020)
Sands Capital is an active, long-term investor in leading innovative businesses globally. Our approach combines rigorous fundamental analysis with creative thinking to identify high-quality growth businesses that are creating the future. Through strategies designed to concentrate investment in these businesses, we serve the long-term growth objectives of institutions and fund sponsors in more than 40 countries.
An independent, staff-owned firm based in the Greater Washington, DC area, Sands Capital managed more than USD $68 billion in client assets as of December 31, 2020.
© 2021 Sands Capital Management. All Rights Reserved.
For institutional and professional investors only.